FROM PUBLIC EVENTS · 2026-11-18

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Early clinical · first deals Has allergy and obesity microneedle patches in clinical trials and signed a CDMO contract with a Japanese company for a sensor patch.

  • Signed a CDMO contract with Murata Manufacturing for a microneedle sensor patch. Source
  • Completed the Phase 2b/3 trial application for DF19001. Source

Roles often seen at this stageResearch & development · Clinical & PV · Manufacturing & MSAT

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-18

Raphas

A drug-delivery company using dissolving microneedle patches to deliver drugs through the skin; its Cheonan plant holds MFDS pharmaceutical manufacturing approval.

DF19001

Phase 1

House-dust-mite allergy immunotherapy patch; Phase 1 was completed in December 2025 and a Phase 2b/3 trial application was filed in May 2026.

Semaglutide microneedle patch

Phase 1

Obesity patch developed with Daewon Pharmaceutical; in a Korean Phase 1 trial it showed about 30% relative bioavailability versus subcutaneous injection.

Microneedle biosensor patch CDMO

Service

Handles formulation, process development and manufacturing of a microneedle biosensor patch for body-fat monitoring developed with Japan's Murata Manufacturing.

Completion reported

Signed a CDMO contract with Murata Manufacturing, through its Japanese subsidiary, to commercialize a microneedle sensor patch.

Official role guide

Raphas careers

Current availability unconfirmed

Observed 2026-11-18

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 4

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 라파스 연혁 ↗라파스 · Published Date unconfirmed · Sources checked 2026-11-18 · Original unavailable
  2. 라파스, '붙이는 알레르기 치료제' 시대 연다… 마이크로니들 의약품 상용화 청신호 ↗이데일리 · Published 2026-06-01 · Sources checked 2026-11-18 · Original unavailable
  3. 라파스, 세계 최초 '세마글루타이드 마이크로니들 패치' 임상 1상 결과 발표 ↗팜뉴스 · Published 2025-04-22 · Sources checked 2026-11-18 · Original unavailable
  4. 라파스, 日 무라타제작소와 '마이크로니들 센서' 상용화 CDMO 계약 체결 ↗더바이오 · Published 2026-07-03 · Sources checked 2026-11-18 · Original unavailable